2024
Senior Associate at df-mp
Diana Leguizamón
Senior Associate
LLM, BSc (Hons) Biology)
Diana Leguizamón has been active in the field of intellectual property since 2002. As a European Patent Attorney and European Patent Litigator (diploma on “Patent Litigation in Europe” (CEIPI)), she can represent clients before the European Patent Office (EPO) and the Unitary Patent Court (UPC). Diana re-joined the firm in 2024 and works at the firm’s Biotechnology and Pharmaceuticals practice group.
Diana Leguizamón
Senior Associate
LLM, BSc (Hons) Biology)
Diana Leguizamón has been active in the field of intellectual property since 2002. As a European Patent Attorney and European Patent Litigator (diploma on “Patent Litigation in Europe” (CEIPI)), she can represent clients before the European Patent Office (EPO) and the Unitary Patent Court (UPC). Diana re-joined the firm in 2024 and works at the firm’s Biotechnology and Pharmaceuticals practice group.
practice areas.
Diana’s technical focus lies in the fields of in cell biology, stem cell biology, molecular biology, targets and antibodies, biogenetics and plant biology/biotechnology. She is involved in patent prosecution concerning European patents. A main focus of her practice is opposition and appeal matters before the European Patent Office.
Diana also has experience in the preparation of freedom-to-operate opinions, and the conduction of IP due diligence projects. Given her in-house experience as Director and Head of IP at Immatics Biotechnologies, she also has significant experience in the handling of international patent portfolios, and a special understanding of clients’ economic and counseling needs from a business perspective.
admissions.
- European Patent Attorney
- European Patent Litigator
references and activities.
- Author of publications in patent and intellectual property law
- Chambers Global - recognized in the area of Intellectual Property for Germany "foreign experts" and Colombia "experts based abroad" (2013 and 2014)
curriculum vitae.
2021-2023
Director and Head of IP in a global biotechnology company (Immatics Biotechnologies GmbH)
2020
European Patent Attorney at df-mp
2019-2020
Diploma for patent litigation in Europe at the Centre d’Études Internationales de la Propriété Intellectuelle (CEIPI) — Qualification for representation before the Unified Patent Court (UPC)
2010-2019
European Patent Attorney and Senior Associate at the IP Department of the International Law Firm Jones Day
2007-2009
Apprentice in the Life Science Department of the IP Law Firm Vossius & Partner
2006-2009
Doctoral Researcher — Max Planck Institute for Intellectual Property, Competition and Tax Law. Dissertation: “Legal protection of new plant varieties and modern plant breeding in Latin American countries”
2005-2006
Master of Laws in Intellectual Property (LL.M. IP), Munich Intellectual Property Law Center (MIPLC). Master thesis: “Patent protection of biotechnological inventions in Colombia: present issues and perspectives”.
2003-2005
Patent Engineer at IP Law Firm Cavelier Abogados — Bogotá, Colombia
2002-2003
Specialist in Industrial Property Law, Copyright and New Technologies — Universidad Externado de Colombia, Bogotá. Intellectual property law in the Andean Community.
2002-2003
Specialist in Industrial Property Law, Copyright and New Technologies — Universidad Externado de Colombia, Bogotá. Intellectual property law in the Andean Community.
1997-2002
B.Sc. with Honours in Biology from the University of Saskatchewan, Canada
publications.
- 2005: Patentes de segundo uso en la Comunidad Andina. Latin Counsel.com.
See: http://www.latincounsel.com/esp/noticiaampliada.php?nid=4893 - 2005: Use and second use patents in the Andean Community. Infolex. Cavelier Abogados.
See: http://www.cavelier.com/English/index1.htm - 2010: European Court of Justice Restricts Scope of Biotech Patents in Europe: Monsanto Loses Dispute on Soy Meal. Jones Day - Commentary. See: https://bit.ly/2NHztcP
- 2013: The EPO Rescinds its Current Practice for Divisional Filings. Internal Publication. Jones Day – Commentary. See: https://bit.ly/30lmMGa
- 2013: EPO Will Allow Payment of Additional Search Fees for European Regional Phase Applications. Jones Day – Commentary. See: https://bit.ly/2S1qd1X
- 2015: Clarifying or Confirming the Extent of Process Exclusion under Art. 53(b) EPC?
Decisions G 2/12 and G 2/13 of the Enlarged Board of Appeal of the European Patent Office. Jones Day – Commentary. See: https://bit.ly/2FYP41h - 2015: EPO: Minor Text Changes to Patent Application Need Not Slow Grant Process. Jones Day – Commentary. See: https://bit.ly/2LHDco9
- 2015: Partial Priority and Dealing with "Toxic Divisionals" under the European Patent Convention
A New Referral to the EPO Enlarged Board of Appeal: Beyond G 2/98. Jones Day – Commentary. See: https://bit.ly/2Jor5el - 2016: EPO Announces Streamlined Opposition Proceedings. Jones Day – Commentary. See: https://bit.ly/2xBow1w
- 2016: Clarifying or Confusing? The European Commission Chews on Tomatoes and Broccoli. Jones Day – Commentary. See: https://bit.ly/2NGByWJ
- 2017: Clarifying or Conforming? The EPO Bows to the European Commission. Jones Day – Commentary. See: https://bit.ly/2LHC3wR
- 2018: Two Down, One to Go: The UK Ratifies Unified Patent Court Agreement. Jones Day – Commentary. See: https://bit.ly/2S0JKiO
YOUR PARTNER
For Patents. Trademarks. Designs.
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB © 2024 df-mp | Your partner for Patents. Trademarks. Designs. All Rights Reserved.
